ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,253,877 | -2.3% | 158,571 | -2.6% | 0.01% | 0.0% |
Q2 2023 | $3,331,129 | -8.1% | 162,772 | -25.0% | 0.01% | 0.0% |
Q1 2023 | $3,622,832 | -22.1% | 217,066 | -9.1% | 0.01% | -28.6% |
Q4 2022 | $4,647,710 | +25.1% | 238,834 | -2.8% | 0.01% | +16.7% |
Q3 2022 | $3,714,000 | +19.5% | 245,637 | -0.5% | 0.01% | +20.0% |
Q2 2022 | $3,109,000 | -30.2% | 246,768 | -9.5% | 0.01% | -16.7% |
Q1 2022 | $4,456,000 | -28.5% | 272,731 | +1.1% | 0.01% | -14.3% |
Q4 2021 | $6,232,000 | -23.9% | 269,804 | -0.9% | 0.01% | -36.4% |
Q3 2021 | $8,193,000 | +3.0% | 272,268 | +51.5% | 0.01% | 0.0% |
Q2 2021 | $7,958,000 | – | 179,683 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 715,880 | $9,851,000 | 11.04% |
RTW INVESTMENTS, LP | 15,802,802 | $217,447,000 | 5.62% |
Amitell Capital Pte Ltd | 97,331 | $1,339,000 | 3.05% |
Prosight Management, LP | 276,802 | $3,809,000 | 3.00% |
TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $17,419,000 | 2.64% |
Affinity Asset Advisors, LLC | 250,466 | $3,446,000 | 1.45% |
COWEN AND COMPANY, LLC | 1,000,000 | $13,760,000 | 1.33% |
Boxer Capital, LLC | 1,466,051 | $20,173,000 | 1.28% |
Cormorant Asset Management, LP | 868,550 | $11,951,000 | 0.90% |
MAVERICK CAPITAL LTD | 2,532,366 | $34,845,000 | 0.86% |